Company / Goodwill
ANI Pharmaceuticals, Inc. Goodwill History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$62.5M
FY2025
5-year range
$27.9M / $62.5M
FY2021-FY2025
Trend
+4.2%
vs FY2024
Sector context
#44 of 74
Health Care
What the data says
At $62M, ANI Pharmaceuticals, Inc.'s goodwill ranks #44 of 74 in the Health Care sector. Improved from $28M to $62M over the past 2 years.
Based on SEC 10-K filings.
$62M in FY2025 with a 5-year CAGR of +77.2%.
Improved from $28M to $62M over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +30.3%
- 5-Year CAGR
- +77.2%
- 10-Year CAGR
- -
Sector benchmark
#44 of 74 in Health CareTop 59% of 74This company $62.5M Sector average $4.0B
▼
-98.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +77.2%, indicating consistent growth.
- In FY2025, goodwill increased 4.2% year-over-year.
- Ranks #44 out of 74 companies in the Health Care sector.
- Lowest goodwill in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $62.5M | +4.2% |
| FY2024 | $60.0M | +112.6% |
| FY2023 | $28.2M | +0.0% |
| FY2022 | $28.2M | +1.2% |
| FY2021 | $27.9M | +679.0% |
| FY2020 | $3.6M | +0.0% |
| FY2019 | $3.6M | +0.0% |
| FY2018 | $3.6M | +94.8% |
| FY2017 | $1.8M | +0.0% |
| FY2016 | $1.8M | +0.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026